Showing results (491-500 of 498) with videos related to
Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 498 results.
Plos Genetics|February 18, 2021
Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong populationMullin Ho Chung Yu, Marcus Chun Yin Chan, Claudia Ching Yan Chung, et al.Journal of the American College of Cardiology|September 11, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCMSheila M Hegde, Xiaowen Wang, Pablo Garcia-Pavia, et al.The New England Journal of Medicine|September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic CardiomyopathyPablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.Journal of the American College of Cardiology|December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM TrialAndrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.Journal of the American College of Cardiology|January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic CardiomyopathyMichael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.Science Immunology|April 19, 2024
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.Pageof 50